References
- Abry E, Thomassen IO, Salvesen OO, Torp SH : The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study. Pathol Res Pract 206 : 810-815, 2010 https://doi.org/10.1016/j.prp.2010.09.002
- Cho H, Ha SY, Park SH, Park K, Chae YS : Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas. J Korean Med Sci 14 : 199-205, 1999 https://doi.org/10.3346/jkms.1999.14.2.199
- Csonka T, Murnyak B, Szepesi R, Bencze J, Bognar L, Klekner A, et al. : Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence. Folia Neuropathol 54 : 114-126, 2016
- De Carvalho GTC, Da Silva-Martins WC, De Magalhaes KCSF, Nunes CB, Soares AN, Tafuri LSA, et al. : Recurrence/regrowth in grade I meningioma: how to predict? Front Oncol 10 : 1144, 2020 https://doi.org/10.3389/fonc.2020.01144
- Kumar S, Kakkar A, Suri V, Kumar A, Bhagat U, Sharma MC, et al. : Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: adjuncts to histopathological grading and predictors of aggressive behavior. Neurol India 62 : 376-382, 2014 https://doi.org/10.4103/0028-3886.141248
- Lam WW, Hatada I, Ohishi S, Mukai T, Joyce JA, Cole TR, et al. : Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic beckwith-wiedemann syndrome (BWS) provides a novel genotypephenotype correlation. J Med Genet 36 : 518-523, 1999 https://doi.org/10.1136/jmg.36.7.518
- Latic D, Pejic S, Savic S, Loncar Z, M Nikolic I, Nikolic G, et al. : Cyclin D1 and p57 expression in relation to clinicopathological characteristics and overall survival in patients with renal cell carcinoma. J BUON 24 : 301-309, 2019
- Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, et al. : The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131 : 803-820, 2016 https://doi.org/10.1007/s00401-016-1545-1
- Madhuri TK, Tailor A, Haagsma B, Coley H, Butler-Manuel S : Relevance of immunohistochemical expression of p57kip2 in epithelial ovarian carcinoma- a systematic literature review. J Ovarian Res 5 : 46, 2012 https://doi.org/10.1186/1757-2215-5-46
- Mehidine H, Refregiers M, Jamme F, Varlet P, Juchaux M, Devaux B, et al. : Molecular changes tracking through multiscale fluorescence microscopy differentiate meningioma grades and non-tumoral brain tissues. Sci Rep 11 : 3816, 2021 https://doi.org/10.1038/s41598-020-78678-4
- Pavelin S, Becic K, Forempoher G, Mrklic I, Pogorelic Z, Titlic M, et al. : Expression of Ki-67 and p53 in meningiomas. Neoplasma 60 : 480-485, 2013 https://doi.org/10.4149/neo_2013_062
- Pecina-Slaus N, Kafka A, Vladusic T, Tomas D, Logara M, Skoko J, et al. : Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression. Int J Exp Pathol 97 : 159-169, 2016 https://doi.org/10.1111/iep.12186
- Rossi MN, Antonangeli F : Cellular response upon stress: p57 contribution to the final outcome. Mediators Inflamm 2015 : 259325, 2015 https://doi.org/10.1155/2015/259325
- Telugu RB, Chowhan AK, Rukmangadha N, Patnayak R, Phaneendra BV, Prasad BC, et al. : Histopathological and immunohistochemical evaluation of meningiomas with reference to proliferative markers p53 and Ki67. J Clin Diagn Res 10 : EC15-EC19, 2016
- Tesio M, Trumpp A : Breaking the cell cycle of HSCs by p57 and friends. Cell Stem Cell 9 : 187-192, 2011 https://doi.org/10.1016/j.stem.2011.08.005
- Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW : Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 79 : 574-580, 2008 https://doi.org/10.1136/jnnp.2007.121582
- Zhang X : Expression, correlation and prognostic significance of CD133, P57 and HSF1 in meningioma. Eur Rev Med Pharmacol Sci 21 : 4600-4605, 2017